Edition:
United States

Audentes Therapeutics Inc (BOLD.OQ)

BOLD.OQ on NASDAQ Stock Exchange Global Market

33.51USD
16 Feb 2018
Change (% chg)

-- (--)
Prev Close
$33.51
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
112,183
52-wk High
$41.80
52-wk Low
$14.00

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.00 -0.881
Jun '17 0.00 -0.867
Mar '17 0.00 -0.833
FY 2016 Dec '16 0.00 -0.902
Sep '16 0.00 -0.936
Jun '16 0.00 -0.674
Mar '16 0.00 -0.498
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 6 0.00 0.00 0.00 0.00
Quarter Ending Jun-18 6 0.00 0.00 0.00 0.00
Year Ending Dec-18 9 0.00 0.00 0.00 0.00
Earnings (per share)
Quarter Ending Mar-18 8 -0.91 -0.78 -1.24 -0.54
Quarter Ending Jun-18 8 -0.93 -0.77 -1.30 -0.53
Year Ending Dec-18 9 -3.70 -3.20 -5.31 -3.76
LT Growth Rate (%) 1 -2.10 -2.10 -2.10 2.60
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 178.11 34.43
P/E High - Last 5 Yrs. -- 280.23 46.75
P/E Low - Last 5 Yrs. -- 91.71 24.14
Beta -- 0.82 0.81
Price to Sales (TTM) -- 140.57 8.57
Price to Book (MRQ) 5.68 18.76 5.14
Price to Tangible Book (MRQ) 7.26 25.38 6.30
Price to Cash Flow (TTM) -- 118.58 25.75
% Owned Institutions 80.57 12.07 2.33

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.52
Dividend Yield - 5 Year Avg -- 0.20 2.01
Dividend 5 Year Growth Rate -- 1.85 5.27
Payout Ratio(TTM) -- 9.21 42.77

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 43.07 9.45
Sales (TTM) vs TTM 1 Yr. Ago -- 45.64 7.30
Sales - 5 Yr. Growth Rate -- 32.43 10.21
EPS (MRQ) vs Qtr. 1 Yr. Ago 5.86 0.41 20.15
EPS (TTM) vs TTM 1 Yr. Ago -34.97 -- --
EPS - 5 Yr. Growth Rate -- 44.88 11.48
Capital Spending - 5 Yr. Growth Rate -- 41.98 14.76

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.78 2.42
Current Ratio (MRQ) 12.04 6.17 3.38
LT Debt to Equity (MRQ) 2.16 16.64 11.85
Total Debt to Equity (MRQ) 2.26 18.80 15.12
Interest Coverage (TTM) -- -165.32 38.50

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 50.23 54.90
Gross Margin - 5 Yr. Avg. -- 55.34 52.64
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -567.40 9.86
Operating Margin (TTM) -- -697.09 1.25
Operating Margin - 5 Yr. Avg. -- -588.12 5.07
Pre-Tax Margin (TTM) -- -664.73 2.12
Pre-Tax Margin - 5 Yr. Avg. -- -596.31 5.33
Net Profit Margin (TTM) -- -659.23 -1.38
Net Profit Margin - 5 Yr. Avg. -- -600.20 1.62
Effective Tax Rate (TTM) -- 1.39 22.03
Effective Tax Rate - 5 Yr. Avg. -- 18.11 24.20

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 23,305,201 819,569,446
Net Income/Employee (TTM) -881,845 -626,600 95,804,981
Receivable Turnover (TTM) -- 15.04 5.40
Inventory Turnover (TTM) -- 2.52 3.48
Asset Turnover (TTM) 0.00 0.39 0.90

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -47.65 -1.27 10.68
Return on Assets - 5 Yr. Avg. -- -0.48 12.00
Return on Investment (TTM) -50.99 -1.15 13.54
Return on Investment - 5 Yr. Avg. -- 2.13 15.72
Return on Equity (TTM) -54.54 -20.84 14.80
Return on Equity - 5 Yr. Avg. -- -2.48 16.91
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -344.14 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Audentes Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 91.42%
# of Holders: 134
Total Shares Held: 32,440,004
3 Mo. Net Change: 4,732,788
# New Positions: 27
# Closed Positions: 11
# Increased Positions: 76
# Reduced Positions: 37
# Net Buyers: 39
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.